Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-24

Clinical Trial Update: Sirolimus and Familial Adenomatous Polyposis (FAP) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sirolimus for familial adenomatous polyposis (FAP) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rapamune (sirolimus)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Adenomatous Polyposis Coli | Phase 2 | Status: COMPLETED | Results posted: 2024-10-24